Septic pneumonias resulting from bacterial infections of the lung are a leading cause of human death worldwide. Little is known about the capacity of CD8 T cell-mediated immunity to combat these infections and the types of effector functions that may be most effective. Pneumonic plague is an acutely lethal septic pneumonia caused by the Gram-negative bacterium Yersinia pestis. We recently identified a dominant and protective Y. pestis antigen, YopE 69-77 , recognized by CD8 T cells in C57BL/6 mice. Here, we use gene-deficient mice, Ab-mediated depletion, cell transfers, and bone marrow chimeric mice to investigate the effector functions of YopE 69-77 -specific CD8 T cells and their relative contributions during pulmonary Y. pestis infection. We demonstrate that YopE 69-77 -specific CD8 T cells exhibit perforin-dependent cytotoxicity in vivo; however, perforin is dispensable for YopE 69-77 -mediated protection. In contrast, YopE 69-77 -mediated protection is severely impaired when production of TNFa and IFNc by CD8 T cells is simultaneously ablated. Interestingly, TNFa is absolutely required at the time of challenge infection and can be provided by either T cells or non-T cells, whereas IFNc provided by T cells prior to challenge appears to facilitate the differentiation of optimally protective CD8 T cells. We conclude that cytokine production, not cytotoxicity, is essential for CD8 T cell-mediated control of pulmonary Y. pestis infection and we suggest that assays detecting Ag-specific TNFa production in addition to antibody titers may be useful correlates of vaccine efficacy against plague and other acutely lethal septic bacterial pneumonias. 
Introduction
Plague, one of the world's most deadly infectious diseases, has killed hundreds of millions of humans during three major pandemics [1] . It is caused by the Gram-negative facultative intracellular bacterium Yersinia pestis, which is naturally maintained in rodent reservoirs. Fleas transmit Y. pestis between rodents and to other mammals. Human infections typically result from fleabites as well, but a pneumonic form of plague can spread from human to human via infectious respiratory droplets. Pneumonic plague is fulminant and nearly always fatal unless treated with antibiotics within 24 h of symptom onset. Although natural outbreaks of pneumonic plague are uncommon, the high mortality rate, small window for treatment, existence of antibiotics-resistant strains, and potential for use as an airborne biological weapon fosters research aimed at the development of effective countermeasures.
Mouse models of pulmonary Y. pestis infection are considered translational tools for the development of pneumonic plague countermeasures because the pathology of plague in rodents is highly similar to that observed in humans. Analogous septic pneumonias caused by more common bacteria, including members of the Klebsiella, Streptococcus, and Staphylococcus species, are leading causes of death worldwide [2, 3] . Thus, murine models of plague also provide tools for studying basic mechanisms of immune defense against acutely lethal bacterial infections that seed the human lung and then disseminate to cause septic morbidity.
Ab-based subunit vaccines composed of the Y. pestis F1 and LcrV proteins provide rodents and some nonhuman primates with substantial protection against pulmonary Y. pestis infection [4] . Despite inducing high titer Ab responses, these vaccines fail to induce adequate protection in all nonhuman primates, most notably in African green monkeys [4, 5, 6] . This observation raises the possibility that Abs may not suffice to protect humans against pneumonic plague. Recent studies indicate T cells also contribute to protection against pulmonary Y. pestis infection in mice and the cytokines TNFa, IFNc and IL-17 are required for optimal T cellmediated protection [7, 8] . For example, B cell-deficient mice vaccinated with live attenuated Y. pestis are protected against lethal challenge, and depleting T cells or neutralizing TNFa and IFNc at the time of challenge fully abolishes the protection [7] . TNFa and IFNc also contribute to Ab-mediated protection in wild-type mice: the passive protection conferred by therapeutic administration of F1 and LcrV-specific mAb and the active protection conferred by immunization with a recombinant F1/LcrV vaccine are both abolished by neutralization of TNFa and IFNc [9, 10] . Together, these findings suggest that pneumonic plague vaccines should also aim to induce cellular immunity that produces cytokines, in addition to inducing Ab-mediated humoral immunity.
CD8 T cells are critical for defense against a variety of pathogens, including viruses, protozoa and bacteria [11, 12] . The effector functions used by CD8 T cells to resist pathogens include secretion of cytokines like TNFa and IFNc and Ag-specific cytolysis of infected cells [11, 12] . Recently we identified a dominant and protective T cell epitope recognized by Y. pestisspecific CD8 T cells [13] . Immunizing wild-type C57BL/6 mice with this single peptide, YopE 69-77 , primes Ag-specific CD8 T cells that suffice to confer protection against lethal pulmonary Y. pestis challenge [13] . Moreover, immunizing mice with YopE 69-77 also elicits a CD8 T cell response that protects against lethal intragastric challenge with Yersinia pseudotuberculosis, the enteropathogen from which Y. pestis evolved [14] . A prior study showed that CD8 T cells and perforin, a key molecule for cytolysis, are required to protect naïve mice against attenuated Y. pseudotuberculosis infection [15] . However, the relative contributions of cytokines and cytolysis to CD8 T cell-mediated anti-Yersinia immunity in vivo have never been reported. Furthermore, it is not yet clear whether T cells or other cell types produce the TNFa and IFNc required for effective T cell-mediated defense against plague.
In this study, we examined the effector functions of YopE 69-77 -specific CD8 T cells during pulmonary Y. pestis infection, and investigated their relative contributions to protection mediated by YopE 69-77 immunization. Using a combination of gene-deficient mice, Ab-mediated depletion, cell transfers, and bone marrow chimeric mice, we demonstrate that YopE 69-77 -specific CD8 T cells exhibit perforin-dependent cytotoxicity in vivo, but perforin is dispensable for YopE 69-77 -specific CD8 T cell-mediated protection. In contrast, TNFa and IFNc are critical for protection and YopE 69-77 -mediated protection is severely impaired when production of TNFa and IFNc by CD8 T cells is simultaneously suppressed.
Results

Immunization with YopE 69-77 confers protection against Y. pestis
Prior studies established that intranasal immunization with YopE 69-77 , a dominant CD8 T cell epitope of the Y. pestis YopE protein, confers C57BL/6 mice with CD8 T cell-mediated protection against pulmonary Y. pestis infection [13] ; however, the mechanism of protection has yet to be defined. To investigate the relative contributions of cytokines and cytolysis to YopE 69-77 -specific CD8 T cell-mediated protection, we first examined the protective efficacy of YopE 69-77 immunization. Wild-type C57BL/6 mice were immunized intranasally with adjuvant cholera toxin (CT) alone or adjuvant with 1 mg of YopE [69] [70] [71] [72] [73] [74] [75] [76] [77] and then challenged intranasally with Y. pestis. As previously described [13] , immunization with YopE 69-77 conferred protection against 20 median lethal dose (MLD) of Y. pestis strain D27, with 80% YopE 69-77 -immunized mice surviving the lethal challenge ( Figure 1A ). Immunization with YopE 69-77 also conferred significant protection against a higher dose (200 MLD) challenge of Y. pestis strain D27 ( Figure 1B) , with 67% mice surviving. Moreover, immunization with YopE 69-77 even sufficed to confer modest yet significant protection against intranasal challenge with fully virulent pigmentation locus-positive Y. pestis strain CO92 ( Figure 1C ). Although 75% of YopE 69-77 -immunized mice ultimately succumbed to the fully virulent challenge, protection was evidenced by both a 1.5-day prolongation in median survival time and an increase in the overall survival rate ( Figure 1C ). These data indicate that YopE 69-77 immunization confers significant CD8 T cell-mediated protection against lethal pulmonary challenge with multiple Y. pestis strains. To investigate the mechanism of CD8 T cell-mediated defense in vivo, we focused on the model employing 20 MLD of Y. pestis strain D27 challenge, as this model showed the greatest degree of protection.
Mice immunized with YopE 69-77 exhibit perforindependent cytotoxic activity
To test whether immunization with YopE elicits a CTL response, we measured the ability of YopE 67-77 -specific CD8 T cells to lyse peptide-pulsed autologous primary lymphocytes using a standard in vivo CTL assay [16] . Naïve splenocyte target cells from CD45.1 congenic C57BL/6 mice were pulsed with YopE 69-77 peptide and labeled with a high concentration of CFSE. Control target cells were pulsed with OVA 257-264 peptide and labeled with a low concentration of CFSE. The pulsed cells were then mixed at a one-to-one ratio and injected intravenously into wild-type C57BL/6 mice that had been previously immunized. Approximately 20 h later, splenocytes were harvested and the proportion of transferred target cells labeled with high or low levels of CFSE was determined by flow cytometry. The proportion of cells recovered from naïve C57BL/6 mice was used as the comparator (Figure 2A, a) .
As expected, near equal proportions of both target cell populations were recovered from mice immunized with CT adjuvant alone, indicating that no specific lysis was taking place (Figure 2A 
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suggest that immunization with YopE 69-77 primes T cells that have the ability to specifically kill YopE 69-77 -pulsed target cells in vivo.
Perforin can play a critical role in CD8 T cell-mediated cytotoxicity, and perforin-deficient mice display increased susceptibility to many viral, bacterial and protozoan infections [11, 12, 17] . To investigate whether perforin contributes to YopE 69-77 -specific CD8 T cell-mediated cytotoxicity, Ag-pulsed target cells were transferred into immunized perforin-deficient mice and the CTL assay was performed. The YopE 69-77 -and OVA 257-264 -immunized perforin-deficient mice showed significantly reduced cytotoxic activity against YopE 69-77 -and OVA 257-264 -pulsed target cells, respectively, in comparison with immunized wild-type mice ( Figures 2B and 2C ). The reduced cytotoxicity could not be explained by reduced T cell priming, as the peripheral blood of the immunized wild-type and perforin-deficient mice harbored comparable percentages of YopE 69-77 -specific ( Figure 2D ) or OVA 257-264 -specific ( Figure 2E ) CD8 T cells. These data demonstrate that YopE 69-77 -specific CD8 T cells have the ability to kill YopE 69-77 -pulsed target cells in vivo in a perforin-dependent manner.
Perforin is dispensable for YopE 69-77 -specific CD8 T cellmediated protection against Y. pestis and Y. pseudotuberculosis
We next investigated whether perforin is required for protection against lethal Y. pestis challenge. Wild-type or perforin-deficient mice were immunized with YopE 69-77 and then challenged intranasally with 20 MLD of Y. pestis strain D27. As shown in Figure 3A , most control mice immunized with adjuvant alone or with control peptide OVA 257-264 succumbed to Y. pestis challenge, whereas most wild-type and perforin-deficient mice immunized with YopE 69-77 survived. Similar results were observed when mice were immunized with either 1 mg or 10 mg YopE 69-77 ( Figure 3A zand data not shown). Measurements of bacterial burden in lung and liver tissues at day 4 after Y. pestis challenge showed significantly decreased numbers of CFU in both the YopE 69-77 -immunized wildtype and perforin-deficient mice, as compared with control mice immunized with adjuvant alone or with OVA 257-264 ( Figure 3B ). Neither the survival data nor the bacterial burden data revealed a significant role for perforin in the YopE 69-77 -specific CD8 T cellmediated protection against Y. pestis. Therefore, although the YopE 69-77 -specific CD8 T cells exhibit perforin-dependent cytotoxic activity in vivo (Figure 2 ), perforin is dispensable for protection against lethal Y. pestis challenge.
We previously demonstrated that immunization with YopE 69-77 also protects against lethal intragastric challenge of mice with Y. pseudotuberculosis [14] . Other investigators reported that naïve perforin-deficient mice display increased susceptibility to intravenous challenge with an attenuated Y. pseudotuberculosis strain [15] . To investigate whether perforin is required for YopE 69-77 -specific CD8 T cell-mediated protection against Y. pseudotuberculosis, we immunized wild-type and perforin-deficient mice and challenged intragastrically or intravenously with 10 MLD of virulent Y. pseudotuberculosis strain 32777. We observed that both wild-type and perforin-deficient mice immunized with YopE 69-77 were specifically protected against intragastric and intravenous Y. pseudotuberculosis challenge ( Figures 3C and 3D , respectively). These data indicate that perforin is also dispensable for YopE 69-77 -specific CD8 T cell-mediated protection against Y. pseudotuberculosis. Figure 4A and 4B) . Notably, the wild-type and IFNc-deficient mice generated comparable frequencies of YopE 69-77 -specific CD8 T cells after immunization, and despite their impaired survival, the TNFa-deficient mice consistently generated higher frequencies of specific cells (data not shown), implying that cytokine deficiency does not quantitatively impair the expansion and/or persistence of YopE 69-77 -specific CD8 T cells. These results suggest that TNFa and IFNc play critical roles during YopE 69-77 -specific CD8 T cell-mediated protection against pulmonary Y. pestis infection. To assess whether protection mediated by YopE 69-77 -specific CD8 T cells requires cytokines at the time of challenge, YopE 69-77 -immunized wild-type mice were treated with neutralizing mAb specific for TNFa or IFNc. Control mice were treated with an isotype-matched mAb of irrelevant specificity. As shown in Figure 4C , while mice treated with mAb to neutralize IFNc at the time of challenge displayed decreased but still significant protection (p,0.01), nearly all mice treated with mAb to neutralize TNFa succumbed. These results suggest that production of TNFa is particularly critical at the time of pulmonary Y. pestis challenge.
TNFa produced by either macrophages/neutrophils or T cells is dispensable for YopE 69-77 -specific CD8 T cellmediated protection against Y. pestis
A variety of cell types can produce TNFa during the immune response to infection. To assess whether a specific cell type is responsible for producing the critical TNFa during CD8 T cellmediated defense against Y. pestis, we performed studies with previously described mice possessing cell-type-specific deficiencies in TNFa expression [18] . Control mice and mice deficient for TNFa expression in either the macrophage/neutrophil lineage (MN-TNF KO) or the T cell lineage (T-TNF KO) were immunized with YopE 69-77 . Immunized TNF-floxed littermate control mice largely survived challenge with 20 MLD of Y. pestis strain D27 ( Figure 5 ). Unexpectedly, both the MN-TNF KO mice and the T-TNF KO mice were also protected by YopE 69-77 immunization, with 90% and 80% surviving the lethal challenge, respectively (Figures 5A and 5B, respectively). These data suggest that TNFa derived from either macrophages/neutrophils or T cells can suffice to confer YopE 69-77 -mediated protection against pulmonary Y. pestis challenge.
Neither TNFa nor IFNc production by T cells is critical for YopE 69-77 -specific CD8 T cell-mediated protection against Y. pestis
To definitively assess whether CD8 T cells are required to produce TNFa or IFNc, we next assayed protection conferred by primed CD8 T cells isolated from YopE 69-77 -immunized TNFaor IFNc-deficient mice. Specifically, wild-type, TNFa-deficient, or IFNc-deficient mice were immunized with YopE 69-77 and their CD8+ splenic T cells were purified by magnetic beads and injected intravenously into naïve wild-type recipient mice, which were then challenged with 20 MLD of Y. pestis strain D27. The mice that received CD8+ T cells from YopE 69-77 -immunized wild-type mice showed significantly improved survival as compared with mice that received CD8+ T cells from control adjuvant-immunized mice (p,0.0001), with 43% of the mice surviving ( Figure 6A ). Mice that received CD8+ T cells from YopE 69-77 -immunized TNFa-or IFNc-deficient mice displayed more modest but significant protection (both p,0.05), with 29% and 27% surviving the challenge, respectively. Thus, YopE 69-77 -specific CD8 T cells lacking the capacity to produce either TNFa or IFNc can confer significant protection against Y. pestis.
In our experience, the transfer of primed T cells followed shortly thereafter by an infectious challenge can sometimes provide nonspecific protection (data not shown), perhaps owing to the potential of effector and memory CD8 T cells to rapidly secrete IFNc in response to IL-12 and IL-18 in the absence of cognate antigen [19] . In fact, the mice that received CD8+ T cells from OVA 257-264 -immunized wild-type mice displayed some protection, with 24% surviving the challenge ( Figure 6A) . Moreover, the protection in this primed T cell transfer model was relatively weak, as compared with our prior studies of intact mice, thus making it difficult to study the mechanism. Additionally, these YopE 69-77 -specific CD8 T cells were primed in an environment where cytokine was deficient. In an attempt to overcome these possible caveats to the experiments shown in Figure 6A , we next developed a model to study cytokine-deficient T cells that were primed in situ. First, we isolated naïve splenocytes from wild-type or genedeficient mice and transferred them to TCRbd-deficient mice, which lack T cells, thus creating chimeric mice in which primed T cells could only arise from cytokine-deficient donor splenocytes. Then, we immunized and challenged these splenocyte chimeras. The chimeras that received wild-type splenocytes showed significant YopE-specific protection (p,0.0001); 70% of the YopE 69-77 -immunized mice survived and only 7% of the control OVA 257-264 -immunized mice survived ( Figure 6B ). All the YopE 69-77 -immunized mice that received splenocytes from perforin-deficient mice also survived, further confirming that perforin is dispensable for protection against Y. pestis mediated by primed CD8 T cells ( Figure 6B ). YopE 69-77 -immunized mice that received splenocytes from TNFa-deficient or IFNc-deficient mice also displayed significant protection (both p,0.0001), exhibiting 56% and 70% survival, respectively. Thus, mouse models employing either the transfer of primed CD8+ T cells (Figure 6A ) or the priming of CD8+ T cells in situ ( Figure 6B ) demonstrate that YopE 69-77 -specific CD8 T cells lacking the capacity to produce either TNFa or IFNc can confer significant protection against Y. pestis.
TNFa and
To explore this possibility, we generated TNFa and IFNc double-deficient (TNFa/IFNc-deficient) mice. We observed that T cell-deficient mice that received splenocytes from TNFa/IFNc-deficient mice were poorly protected by YopE 69-77 immunization ( Figure 6B ), with only 18% surviving lethal Y. pestis challenge. The observation that further removing the remaining cytokine from either the TNFa-or IFNcdeficient mice leads to a significant and substantial decrease in survival suggests complementary roles for TNFa and IFNc produced by CD8 T cells.
In the splenocyte chimera model shown in Figure 6B , the cytokine-deficient splenic T cells had developed in the thymuses of cytokine-deficient mice, perhaps imprinting them with altered functions. To overcome this potential concern, a final set of studies was performed using mixed bone marrow chimeras. Lethally irradiated TCRbd-deficient mice were reconstituted with a mixture of bone marrow cells isolated from gene-deficient or wild-type mice. In each case, 75% of the bone marrow cells came from TCRbd-deficient mice, thereby enabling reconstitution of wild-type elements of all leukocyte populations except for T cells. The remaining 25% of the bone marrow cells came from wild-type mice or gene-deficient mice, thereby enabling the development of wild-type or gene-deficient T cells, respectively. Six weeks after reconstitution, the mice were immunized and then challenged with 20 MLD of Y. pestis strain D27. As shown in Figure 7A compared with mice reconstituted with IFNc-deficient T cells), with only 18% of mice surviving the lethal challenge ( Figure 7A) .
It is worth noting that we confirmed the efficiency of bone marrow reconstitution and YopE immunization in mice prior to Y. pestis infection by measuring the frequency of CD4 T cells, CD8 T cells, and YopE 69-77 -specific CD8 T cells in the peripheral blood. In spite of slightly lower frequency of CD8 T cells in the peripheral blood of mice reconstituted with TNFa-, IFNc-or TNFa/IFNcdeficient T cells than that of mice reconstituted with wild-type T cells (data not shown), the frequency of YopE 69-77 -specific CD8 T cells, as measured by K b YopE 69-77 tetramer, was not lower than that of mice reconstituted with wild-type T cells ( Figure 7B ). In fact, mice reconstituted with TNFa-deficient T cells generated even more YopE 69-77 -specific CD8 T cells than mice reconstituted with wild-type T cells, even though they exhibited reduced survival ( Figure 7A ).
Subsequently, we generated bone marrow chimeras, immunized and challenged them as described above, and then euthanized mice at day 4 after challenge to measure bacterial burden. This analysis revealed significantly decreased bacterial CFU in lung ( Figure 7C ) and liver ( Figure 7D ) tissues of YopE 69-77 -immunized chimeric mice reconstituted with wild-type, TNFa-or IFNcdeficient T cells, as compared with OVA 257-264 -immunized chimeric mice reconstituted with wild-type T cells. Thus, deficient production of either TNFa or IFNc by T cells does not impair their ability to control bacteria. In contrast, we observed significantly increased numbers of bacterial CFU in lung and liver tissues of YopE 69-77 -immunized chimeric mice reconstituted with TNFa/IFNc-deficient T cells, as compared with YopE 69-77 -immunized chimeric mice reconstituted with wild-type T cells ( Figure 7C and 7D) . In fact, the burden of YopE 69-77 -immunized chimeric mice reconstituted with TNFa/IFNc-deficient T cells achieved levels approaching those of OVA 257-264 -immunized chimeric mice reconstituted with either wild-type or TNFa/ IFNc-deficient T cells, which were not protected ( Figure 7A ).
Discussion
In this study, we conducted experiments to better understand the mechanisms of immunization-induced protective CD8 T cell responses and their relative contributions to defense against pulmonary Y. pestis infection. We extended our prior work [13] and demonstrated that immunization with YopE 69-77 suffices to confer remarkable protection against pigmentation locus-deficient Y. pestis strain D27 ( Figures 1A and 1B) . YopE 69-77 -immunized mice can withstand as high as 200 MLD challenge ( Figure 1B) . Intranasal administration of Y. pestis strain D27 causes mortality in mice but does not cause the fulminant pneumonia characteristic of fully virulent Y. pestis [20] . However, we also found that YopE 69-77 -immunized mice were significantly protected against intranasal infection with the fully virulent Y. pestis strain CO92 ( Figure 1C ). To our knowledge, this is the first report that T cell-mediated immunity can protect against fully virulent Y. pestis infection. Notably, the protection was incomplete, suggesting that YopE 69-77 -specific CD8 T cells alone may be insufficient to combat fully virulent Y. pestis strains.
Taking advantage of the robust protection observed in mice infected with 20 MLD Y. pestis strain D27, we manipulated immune responses to identify effector functions that are critical for CD8 T cell-mediated anti-Yersinia immunity in vivo. Researchers typically use gene-deficient mice, adoptive cell transfer models and Ab-mediated depletion methods to demonstrate roles for different effector functions of cellular immunity during host defense against microbial infections. There are caveats to each approach and determining the relative contribution of each specific effector function by any particular type of immune cell can be technically challenging. First, effector functions usually are not unique to a particular cell type. Both CD8 T cells and NK cells utilize perforin-mediated cell killing, whereas TNFa and/or IFNc can be produced by CD4 T cells, CD8 T cells, NK cells, and some innate cells such as macrophages and neutrophils. Second, the removal of any particular effector function can inadvertently alter cell differentiation, homeostasis, and/or the immunodominance hierarchies of Ag-specific cells. For example, IFNc-deficient and perforin-deficient mice exhibit altered expansion, contraction and immunodominance of Ag-specific CD8 T cells during Listeria infection [21] . Third, effector and memory Ag-specific CD8 T cells have the potential to rapidly secrete IFNc in response to IL-12 and IL-18 in the absence of cognate Ag [19] , hence transferring primed effector/memory Ag-specific cells to mice followed by infection could confer innate protection in an Ag nonspecific manner. In an effort to address these complexities and overcome the limitations of any single methodology, we used multiple approaches to examine the contributions of potential effector mechanisms used by CD8 T cells to combat septic pneumonic plague.
YopE 69-77 -immunized perforin-deficient mice, which display severely impaired Ag-specific cytotoxic activity in vivo (Figure 2) , are resistant to lethal Y. pestis and Y. pseudotuberculosis challenge (Figure 3) . Likewise, the levels of protection provided by wild-type and perforin-deficient YopE 69-77 -specific CD8 T cells are indistinguishable in T cell chimeric mice ( Figure 6B and 7A) . These data strongly suggest that perforin does not contribute substantially to CD8 T cell-dependent adaptive host defense against Yersinia. In contrast, a recent publication by Bergman et al. suggested that perforin can be critical for protection against Y. pseudotuberculosis infection [15] . They studied naïve mice infected with an attenuated strain of Y. pseudotuberculosis and reported that perforin deficiency impaired protection, as evidenced by greater bacterial burden in the spleens and livers. When the surviving perforin-deficient mice were challenged with a virulent strain of Y. pseudotuberculosis, the ''immunized'' perforin-deficient mice only exhibited significantly impaired protection if animals without detectable bacteria were excluded from the analysis. Since we found no evidence that perforin deficiency impairs either bacterial clearance or survival in YopE 69-77 -immunized mice, the combined data suggest that perforin may be important for primary defense against Yersinia but can be dispensable for adaptive defense.
While perforin deficiency has little impact on protection mediated by YopE 69-77 -specific CD8 T cells, we note that perforin deficiency did not completely abolish all cytotoxicity in our model ( Figure 2B) . Thus, we cannot exclude the possibility that the residual cytotoxicity, which is independent of perforin, may contribute to adaptive defense against Yersinia. Future studies will need to assess whether such other cytotoxic pathways, for example, Fas/FasL and TNF/TNF receptors, contribute to YopE 69-77 -specific CD8 T cell-mediated protection.
In contrast to perforin deficiency, cytokine deficiency dramatically impairs anti-Yersinia immunity mediated by YopE 69-77 -specific CD8 T cells. Data presented in this study highlights the complexity of cytokine-mediated protection. YopE 69-77 -immunized mice that completely lack the ability to produce either TNFa or IFNc succumb to infection, suggesting that each of these cytokines are absolutely required for CD8 T cell-mediated antiYersinia immunity (Figures 4A and 4B) . However, the data in Figure 4C reveal that IFNc is not absolutely required for protection at the time of challenge. It implies that IFNc may have a role in the development of YopE 69-77 -specific CD8 T cells that have the capacity to combat Y. pestis. Moreover, the data in Figure 6 reveal that IFNc production by T cells is not required for resistance to Y. pestis, implying that cell types other than T cells must be capable of producing enough IFNc to confer modest yet significant protection. In contrast, chimeric mice in which the T cells cannot produce IFNc exhibit significant impairments in survival after YopE immunization and Y. pestis challenge ( Figure 7A ). While we cannot completely exclude the possibility that cell reconstitution in mice deficient for T cell-derived IFNc is suboptimal, the frequency of YopE 69-77 -specific CD8 T cells in the peripheral blood prior to challenge is similar in wild-type mice and chimeric mice whose T cells cannot produce IFNc ( Figure 7B ). Since other cells in the environment are capable of producing IFNc in that model, the data suggest that a cell-intrinsic defect resulting from the loss of IFNc influences some quality of differentiating CD8 T cells. One possibility is that mice whose T cells cannot produce IFNc may have reduced TNFa production or responsiveness. Indeed, IFNc has been shown to enhance TNF receptor expression [22] .
In contrast to IFNc, Ab-mediated depletion of TNFa at the time of Y. pestis challenge abrogates nearly all protection in YopE 69-77 -immunized mice, suggesting that TNFa is absolutely required for protection at the time of challenge ( Figure 4C) . Cells of the macrophage, neutrophil and T cell lineages can each produce TNFa. However, TNFa production by T cells is not absolutely critical for resistance to Y. pestis, implying that cell types other than CD8 T cells must be capable of producing enough TNFa to confer modest yet significant protection ( Figures 5B, 6 and 7) . We found that TNFa from macrophages/neutrophils is not absolutely required for protection either, at least not when the mice have intact IFNc production ( Figure 5A ). These observations imply that TNFa from one cell type can substitute for the loss of TNFa in another cell type in pulmonary Y. pestis infection. Alternatively, residual production of TNFa from cells other than T cells and macrophages/neutrophils could also contribute to protection.
In contrast to the dramatic impact of Ab-mediated depletion of TNFa at the time of challenge, the impact of depleting CD8 T cellderived TNFa seems to be modest (Figures 6 and 7) . One caveat is that we repeatedly observed a higher frequency of YopE 69-77 -specific CD8 T cells in the peripheral blood of mice whose T cells could not produce TNFa ( Figure 7B and data not shown). Thus, it is conceivable that impairments in protection caused by the absence of T cell-derived TNFa can be restored, at least partially, by an increase in number of YopE 69-77 -specific CD8 T cells.
While depleting either TNFa or IFNc from CD8 T cells impairs protection to a certain extent, simultaneously depleting both cytokines additionally compromises protection. Specifically, chimeric mice whose T cells can produce neither cytokine display significantly reduced survival when compared with mice whose T cells cannot produce either TNFa or IFNc (Figures 6B and 7A) . Some TNFa production from either T cells or non-T cells, in concert with intact IFNc production, appears to be sufficient for near optimal protection ( Figure 5 ). However, the data suggest that TNFa and IFNc production by CD8 T cells work complementarily to confer optimal protection. One likely mechanism by which these cytokines contribute to host survival is through the control of bacterial burden (Figures 7C and 7D ). TNFa and IFNc are known to activate macrophages and neutrophils to produce reactive nitrogen and oxygen intermediates that assist in the control of intracellular bacteria. Adding purified TNFa and IFNc to the macrophage cultures can overcome Y. pestis-induced suppression of macrophage anti-bacterial activity in vitro [23] . These cytokines can also stimulate neutrophils to secret antimicrobial molecules to control extracellular bacteria.
Although depleting both TNFa and IFNc produced by T cells dramatically compromises the protection mediated by YopE 69-77 -specific CD8 T cells, it does not completely abolish the protection. We did observe a minimal of 20% host survival, which is significant in comparison with OVA 257-264 -immunized wild-type mice and reproducible. This finding implies that while CD8 T cellderived TNFa and IFNc are critical for host defense against Y. pesitis, they may not be the sole players. Despite the observation that perforin is dispensable for CD8 T cell-mediated protection against Y. pestis (Figure 3) , its function may contribute to host survival when the two key effector functions of CD8 T cells are absent. Moreover, other mediators that CD8 T cells can produce during infection may also contribute to protection. For example, CD8 T cell production of macrophage inflammatory protein-1a (MIP-1a/CCL3) is required for anti-Listeria immunity [24, 25] .
One could argue that in our splenocyte transfer and bone marrow chimera models ( Figures 6B and 7A , respectively), CD4 T cells share the same defect with CD8 T cells. However, we found that CD4 T cells are not required for YopE 69-77 -mediated protection, since YopE 69-77 -immunized CD4-deficient mice were protected as well as YopE 69-77 -immunized wild-type mice (unpublished data). Thus, we think it unlikely that a deficiency of CD4 T cell-derived cytokines accounts for the lost of protection we observe in these models.
CD8 T cells can utilize a variety of mechanisms to protect against infectious agents. Understanding the effective and critical functions of the CD8 T cell response against pathogens that cause septic bacterial pneumonias and defining the combinations of effector functions that optimally combat such pathogens should improve our ability to design effective vaccines. Our study shows that YopE 69-77 -specific CD8 T cells exhibit perforin-dependent cytotoxic activity in vivo, but this effector function does not appear to be required for anti-Yersinia immunity. In contrast, production of TNFa and IFNc is essential for CD8 T cell-mediated protection. Interestingly, the time at which these cytokines must be produced appears to differ, as does their essential cellular sources. Overall, the data suggest that CD8 T cell-derived TNFa and IFNc exert complementary functions and CD8 T cells require both cytokines to provide optimal defense against pulmonary Y. pestis infection. Our study further suggests cytokine-producing CD8 T cells may be a valuable addition to subunit plague vaccines and assays detecting Ag-specific TNFa production may be a particularly useful correlate of plague vaccine efficacy. Given that septic bacterial pneumonias are a leading cause of death, it will be interesting to determine whether cytokine production, rather than cytolysis, is generally more important for T cell-mediated defense against septic bacterial pneumonias.
Materials and Methods
Ethics statement
All animal studies were conducted in accordance with the Guide for Care and Use of Laboratory Animals of the National Institutes of Heath and approved by Trudeau Institute Animal Care and Use Committee (IACUC protocols # 02-022 and 02-161).
Mice
Wild-type C57BL/6, B6.129S7-Ifng tm1Ts (IFNc-deficient), B6.129S-Tnf tm1Gkl (TNFa-deficient), C57BL/6-Prf1 tm1Sdz (perforin-deficient), B6.129P2-Tcr btm1Mom Tcrd tm1Mom (TCRbd-deficient), B6.SJL-Ptprc a Pepc b /BoyJ (CD45.1) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and then bred in the specific-pathogen-free Trudeau Institute Animal Breeding Facility. TNFa/IFNc double-deficient mice were generated at Trudeau Institute. Mice deficient for TNFa production in macrophage and neutrophils (MN-TNF KO mice) or T cells (T-TNF KO mice) were generated by crossing mice with TNF ''floxed'' genes to mice carrying the LysM-Cre or CD4-Cre transgenes, respectively [18] . All strains are on the C57BL/6 background. Experimental mice were matched for age and sex, and first immunized between 6 and 10 weeks of age.
Bacteria and infections
Pigmentation locus-deficient Y. pestis strain KIM D27 was originally provided by Dr. Robert Brubaker (Michigan State University, East Lansing, MI). Strain D27 bacilli from frozen glycerol stocks were grown overnight at 26uC in Bacto heart infusion broth (Difco Laboratories, Detroit, MI) supplemented with 2.5 mM CaCl 2 . Cultures were then diluted to an OD of 0.1 at 620 nm, regrown for 3-4 h at 26uC, quantified by OD measurement, and then washed and resuspended in saline at the desired concentration. The numbers of bacterial CFU in the inocula were confirmed by plating. Infections were performed by applying 30 ml to the nares of mice that were lightly anesthetized with isoflurane. The intranasal median lethal dose (MLD) for strain D27 is approximately 1610 4 CFU when the bacteria are grown and administered as described above [26] .
The fully virulent pigmentation locus-positive Y. pestis strain CO92 NR-641 was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH. Bacteria from frozen glycerol stocks were grown overnight at 26uC in Bacto heart infusion broth. Cultures were then diluted to an OD of approximately 0.1 at 620 nm, regrown for 2.5-3 h at 26uC, quantified by OD measurement, and prepared at the desired concentration. The numbers of bacterial CFU in the inocula were confirmed by plating. Infections were performed by applying 25 ml to the nares of mice that were lightly anesthetized with isoflurane. Preliminary studies established that the intranasal MLD for strain CO92 is approximately 1610 3 CFU when the bacteria are grown and administered as described above.
Y. pseudotuberculosis serotype O:1 strain 32777 bacilli from frozen glycerol stocks were grown overnight at 26uC in Luria-Bertani medium to reach an OD of approximately 1.2 at 600 nm. The cultures were then washed and resuspended in saline to achieve the desired concentration. For intragastric infections, mice were fasted for 20-21 h and then inoculated with 200 ml of Y. pseudotuberculosis through a 20-gauge feeding needle. For intravenous infections, mice were injected with 200 ml of Y. pseudotuberculosis via the tail vein. The intragastric and intravenous MLD for strain 32777 is approximately 5610 8 CFU and 12 CFU, respectively, when the bacteria are grown and administered as described above.
Immunization with YopE and ovalbumin peptides 
In vivo cytotoxicity assay
Splenocytes harvested from naïve CD45.1+ congenic mice were used as target cells. After lysing red blood cells using ammonium chloride buffer, the splenocytes were pulsed with either YopE 69-77 or OVA 257-264 peptide (10 mM) for 1 h at 37uC in complete medium (DMEM supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 1% penicillin-streptomycin and 55 mM 2-mercaptoethanol). After washing and resuspending in Hank's balanced salt solution, YopE 69-77 -pulsed cells were incubated with 10 mM CFSE and OVA 257-264 -pulsed cells were incubated with 1 mM CFSE for 10z min in a 37uC water bath. CFSE labeling was then stopped by adding FBS to a final concentration of 20%. Cells were washed twice with complete medium and mixed at a 1:1 ratio. A total of 2610 7 cells were then injected intravenously into immunized recipient mice. Spleen cells were collected 20-22 h later and stained with PE-conjugated anti-CD45.1 mAb, biotinconjugated anti-CD45.2 mAb and allophycocyanin-conjugated streptavidin. The frequency of each CFSE-labeled population in the target cell gate (CD45.1+CD45.22) was determined by flow cytometry. Cells injected into naïve C57BL/6 mice were used as controls. The percent specific lysis was determined by the following formula: [1-(ratio of cells recovered from naïve mice/ ratio of cells recovered from infected mice)]6100. For YopEspecific lysis, the ratio of recovery of OVA [257] [258] [259] [260] [261] [262] [263] [264] 
MHC class I tetramer reagent and staining
The allophycocyanin-conjugated MHC class I peptide tetramers K b YopE 69-77 and K b OVA 257-264 were supplied by the NIH Tetramer Facility and the Trudeau Institute Molecular Biology Core Facility, respectively. PBL were obtained from mandibular blood collected in heparin-containing eppendorf tubes. Red blood cells were lysed by treatment with ammonium chloride. Enumeration of YopE 69-77 -specific CD8 T cells by K b YopE 69-77 tetramer staining was described previously [13] . In brief, cells were treated with 1 mg Fc block (clone 2.4G2) for 10 min at 4uC, washed, and incubated with tetramers for 1 h at room temperature. After washing again, cells were stained with anti-CD4-FITC (clone RM4-5) and anti-CD8-PE (clone 53-6.7) for 30 min at 4uC. Data were collected on a BD Bioscience FACSCanto II and analyzed using FlowJo software.
Measurement of survival and bacteria burden
For survival studies, mice were monitored at least once daily after infection. Unresponsive or recumbent mice were considered moribund and euthanized. For measurement of bacterial burden, mice were euthanized by carbon dioxide asphyxiation at the indicated day after infection. Liver and lung tissues were harvested and homogenized in saline. Serial dilutions of the homogenates were plated on blood agar and incubated at 26uC for 48 h.
Cytokine neutralization
Mice were treated with 1 mg mAb specific for TNFa (clone XT3.11, rat IgG1) or IFNc (clone XMG1.2, rat IgG1) diluted in PBS. The mAb were administered intraperitoneally on the day before challenge infection. Control mice received 1-1.6 mg of isotype-matched rat IgG1 mAb (clone HRPN).
Cell purifications and transfers
For primed CD8
+ T cell transfers, donor mice were immunized intranasally as described above on days 0, 7 and 21. At day 36, splenocytes were harvested, red blood cells were lysed and cell suspensions were applied to nylon wool columns to enrich T cells. After incubation at 37uC for 90 min, the nonadherent cells were eluted and CD8+ T cells were purified by magnetic activated cell sorting (MACS; Miltenyi Biotec Inc., Auburn, CA) according to the manufacturer's instructions. The purified cells were incubated at 37uC for 90 min followed by centrifugation to release beads from cells. The purity of CD8+ donor T cells was ,95%. A total of 1610 7 CD8 + T cells were injected intravenously into naïve wildtype C57BL/6 recipient mice. The following day, the recipient mice were challenged with Y. pestis strain D27.
For naïve splenocyte transfers, donor splenocytes were isolated and red blood cells were lysed. After washing, 5610 7 cells were injected intravenously into naïve TCRbd-deficient recipient mice. The recipient mice were then immunized and challenged with Y. pestis strain D27 as described above.
Mixed bone marrow chimeras
TCRbd-deficient mice were lethally irradiated (950 rad provided in two doses) and reconstituted with a total of 1610 7 donor bone marrow cells. The donor cells comprised bone marrow cells from TCRbd-deficient mice mixed with bone marrow cells from wild-type C57BL/6 mice or the indicated gene-deficient mice at a 3 to 1 ratio. Chimeric mice were allowed to reconstitute for 6 weeks before they were immunized and challenged with Y. pestis strain D27.
Statistics
Statistical analyses were performed using the computer program Prism 5 (GraphPad Software). Survival data were analyzed by logrank tests. Bacterial burden data were analyzed by nonparametric Kruskal-Wallis test followed by Dunn's post test; CFU that fell below the detection limit of our assay were assigned values 0.2 log below the detection limit. All other data were analyzed by Student t test or one-way ANOVA as indicated. *p,0.5, **p,0.01, ***p, 0.001, ****p,0.0001; ns, not significant.
